Nidda Healthcare Gmbh

Deals

C/P

Sector

Status

Deal Name

Parent

Leads

Region

Date

Stada Arzneimittel AG

,,,,

CCY	SIZE (M)	TNR	MTY	RNK	MO	SP	FI	TYPE	BNCH	IPT	GDNC	SPRD	CPN	NIC	PRICE
EMJ	413.000	2.3	Mar-14	Jt. Jpertpk	-	-	-	Wwyyh	Z	100.50-101.00	-	391	3.50%	-	588.00000

Tranche Comments

4.7 cl: Registration: 144H/Pvd M; Comments: XXM350u mau bq 3.5% Kwu 2024 (Oallf qdbu 9/20 50%/25%/uad) . Kfxf Eade/VKB(E&K). VEf XEK/Oymy/OBM/KE/STI/Vwqq/BK/Tbu/KI. Yalw 100.50-101.00, eauw 101.00 z E+391 zf QET0% 10/24. BOO E+50.;

Deal Comments

EBO350x hej rn 3.5% 9/30/24.

Use of Proceeds

Yrufhrhvfhy

Refinancing

Yes

Stada Arzneimittel AG

,,,,

Commentary

Upgrade Plan

Deal Flow

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research

COMPANY

FINSIGHT.COM

PRODUCTS

SALES & SUPPORT

Americas

+1 888 997 6610

APAC

+852 3018 1600

EMEA

+44 80817 87364

support@finsight.com